407 results on '"Patil, Chirag G."'
Search Results
2. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial
3. Blockade of a laminin-411 - Notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblastoma growth through tumor-microenvironment crosstalk
4. Hispanic and African American adult brain tumor patients treated at Harbor-UCLA Medical Center compared to Los Angeles County and Torrance, California
5. Data from A Simple Three-dimensional Hydrogel Platform Enables Ex Vivo Cell Culture of Patient and PDX Tumors for Assaying Their Response to Clinically Relevant Therapies
6. Supplementary Figures 1-2 from A Simple Three-dimensional Hydrogel Platform Enables Ex Vivo Cell Culture of Patient and PDX Tumors for Assaying Their Response to Clinically Relevant Therapies
7. Supplementary Data 5 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
8. Data from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
9. Supplementary Data 8 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
10. Supplementary Data 6 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
11. Supplementary Data from A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
12. Supplementary Video from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
13. Supplementary Figure from A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
14. Supplementary Data 2 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
15. Supplementary Data 7 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
16. Supplementary Data 3 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
17. Supplementary Data 4 from Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk
18. Adjuvant Radiosurgery Versus Serial Surveillance Following Subtotal Resection of Atypical Meningioma: A Systematic Analysis
19. Neck Pain and Paralysis Following Trauma
20. A national perspective of adult gangliogliomas
21. Treatment and survival of supratentorial and posterior fossa ependymomas in adults
22. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era
23. Treatment and survival of patients harboring histological variants of glioblastoma
24. Interspinous device versus laminectomy for lumbar spinal stenosis: a comparative effectiveness study
25. The Impact of Inpatient Rehabilitation on Function and Survival of Newly Diagnosed Patients With Glioblastoma
26. Effectiveness of radiotherapy for elderly patients with anaplastic gliomas
27. Complications, Reoperation Rates, and Health-Care Cost Following Surgical Treatment of Lumbar Spondylolisthesis
28. Autofluorescence-Guided Resection of Intracranial Tumor
29. Outcomes of Percutaneous and Paddle Lead Implantation for Spinal Cord Stimulation: A Comparative Analysis of Complications, Reoperation Rates, and Health-Care Costs
30. Trends in Surgical Use and Associated Patient Outcomes in the Treatment of Acoustic Neuroma
31. A Population-Based Study of Inpatient Outcomes After Operative Management of Nontraumatic Intracerebral Hemorrhage in the United States
32. Management of Multifocal and Multicentric Gliomas
33. A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
34. Epidemiology and the Global Burden of Stroke
35. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?
36. A Socioeconomic Survey of Spinal Cord Stimulation (SCS) Surgery
37. Socioeconomic Trends in Deep Brain Stimulation (DBS) Surgery
38. Effect of Insurance and Racial Disparities on Outcomes in Traumatic Brain Injury
39. Predictors of Treatment Delay in Aneurysmal Subarachnoid Hemorrhage Patients
40. National trends in vertebral augmentation procedures for the treatment of vertebral compression fractures
41. National trends in spinal fusion for cervical spondylotic myelopathy
42. Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
43. The Effect of Transfer and Hospital Volume in Subarachnoid Hemorrhage Patients
44. The effect of centralization of caseload for primary brain tumor surgeries: trends from 2001–2007
45. Racial and Gender Disparities and the Role of Primary Tumor Type on Inpatient Outcomes Following Craniotomy for Brain Metastases
46. Inpatient complications, mortality, and discharge disposition after surgical correction of idiopathic scoliosis: a national perspective
47. Intracranial-Pressure Monitoring in Traumatic Brain Injury
48. Intrasellar and Diaphragma Sellae Meningiomas
49. Cyberknife® Radiosurgical Ablation of Meningiomas
50. Meningioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.